Feasibility Study of Barrier Enhancement for Eczema Prevention
Status unconfirmed · Not applicable
Conditions studied: Eczema
In brief
The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.
Key facts
- Study ID
- NCT01142999
- Run by
- Oregon Health and Science University
- People needed
- 46
- Starts
- 2010-05-01
- Expected to finish
- 2012-09-01
- Last updated by the study team
- 2011-08-05
Who can join
Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Participant must have a parent or sibling with a history of at least one of the following: eczema, allergic rhinitis or asthma
- Infant in overall good health
- Mother between the ages of 16 and 45 years of age at delivery; infant from birth thru 6 months of age
- Capable of giving informed consent
You may not qualify if…
- Preterm birth defined as birth prior to 37 weeks gestation
- Major congenital anomaly
- Hydrops fetalis
- Significant dermatitis at birth not including seborrheic dermatitis ("cradle cap")
- Any immunodeficiency disorder or severe genetic skin disorder
- Any other serious condition that would make the use of emollients inadvisable
- Any other major medical problems that the investigator deems may increase the risk of adverse events with the intervention
Where it is running
- Oregon Health & Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.